NCI-H2170 Cells
CAD$545.10*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The NCI-H2170 cell line is derived from a human squamous cell carcinoma of the lung. This cell line is widely used in lung cancer research, particularly for studying the molecular mechanisms underlying squamous cell carcinoma, which is a common and aggressive form of lung cancer. NCI-H2170 cells provide a valuable model for investigating the genetic and epigenetic alterations associated with lung cancer, as well as for testing the efficacy of novel therapeutic agents. NCI-H2170 cells exhibit an epithelial morphology and express markers characteristic of squamous cell carcinoma, including cytokeratins and p63. They harbor genetic mutations typical of lung cancer, such as alterations in the TP53 and CDKN2A genes, which play critical roles in cell cycle regulation and tumor suppression. Researchers use NCI-H2170 cells to explore key signaling pathways involved in lung cancer progression, such as the EGFR, PI3K/Akt, and MAPK pathways. These cells are also employed in drug screening assays to evaluate the effectiveness of chemotherapeutic agents, targeted therapies, and combination treatments. Additionally, NCI-H2170 cells are used to study mechanisms of drug resistance and to develop strategies to overcome it. The relevance of the NCI-H2170 cell line in lung cancer research underscores its importance in advancing our understanding of cancer biology and in the development of new therapeutic approaches for lung cancer patients. |
|---|---|
| Organism | Human |
| Tissue | Lung |
| Disease | Squamous cell carcinoma |
| Synonyms | H2170, H-2170, NCIH2170 |
Characteristics
| Age | Unspecified |
|---|---|
| Gender | Male |
| Ethnicity | European |
| Morphology | Epithelial |
| Growth properties | Adherent |
Regulatory Data
| Citation | NCI-H2170 (Cytion catalog number 305276) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_1535 |
Biomolecular Data
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS, add 2.5 g/L glucose and 10 mM HEPES |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Fluid renewal | 1 to 2 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305276-091024 | Certificate of Analysis | 05. Dec. 2025 | 305276 |
-
Related products
Related products